LeMaitre Vascular Inc (NAS:LMAT)
$ 81.45 +0.63 (+0.78%) Market Cap: 1.86 Bil Enterprise Value: 1.68 Bil PE Ratio: 28.58 PB Ratio: 4.43 GF Score: 100/100

Q4 2024 LeMaitre Vascular Inc Earnings Call Transcript

Feb 27, 2025 / 10:00 PM GMT
Release Date Price: $99.91 (-3.05%)

Key Points

Positve
  • LeMaitre Vascular Inc (LMAT) reported a 14% growth in sales, with income and EPS increasing by 26% and 30% respectively.
  • The company saw significant geographical sales growth, with AIPAC up 21%, AEA 18%, and the Americas 12%.
  • Expansion of the sales team, with a 12% increase in reps and a 29% increase in sales managers, is expected to drive future growth.
  • New international sales offices in Shanghai and Switzerland are expected to reduce customs complexity and boost sales.
  • LeMaitre Vascular Inc (LMAT) has received 16 of 23 MDR CE marks, with further approvals anticipated, which will expedite market entry in various regions.
Negative
  • The company faces challenges with the remaining 7 MDR CE marks, which are expected to be received in 2025.
  • There are uncertainties regarding the actual price increases translating from list prices, especially outside the US.
  • Operating expenses increased by 12% year over year, driven by investments in the sales team.
  • The company is still in the process of expanding its presence in China, with a small sales force relative to the market size.
  • Potential impacts from tariffs and geopolitical factors could affect the supply chain and sales, although currently deemed minimal.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LMAT.OQ - LeMaitre Vascular Inc
Q4 2024 LeMaitre Vascular Inc Earnings Call
Feb 27, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the La May Vascular Q4 2024 financial results conference call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. JJ Pellegrino, Chief Financial Officer of the Mate Vascular. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon and thank you for joining us on our Q4 2024 conference call. With me on today's call is our CEO George LeMay and our President Dave Roberts. Before we begin, I'll read our Safe Harbor statement. Today we will make some forward-looking statements with the meaning
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot